Amgen (AMGN) Stock price: $308.16 TTM EPS: $7 EPS growth: 52.41% Dividend yield: 2.9% Business Overview Amgen is a global pharmaceutical company that focuses on the areas of oncology and hematology, plus kidney, bone, cardiovascular and inflammatory diseases
By targeting multiple hormone pathways simultaneously, it provides a more comprehensive approach that addresses several aspects of metabolism
Conflict of interest MN has been a member of advisory boards or has consulted with AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Fractyl, GlaxoSmithKline, Menarini/Berlin Chemie, Merck, Sharp & Dohme, and Novo Nordisk
The reason for this is that when you have obesity, the regulation of your body weight is dysfunctional
Shaik Mohamed Sayed UF, Moshawih S, Goh HP, Kifli N, Gupta G, Singh SK, et al
Our medical team will assess your health history, weight loss goals, and any underlying conditions before recommending a treatment plan